1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Aneurysm-Pipeline Insights, 2017

Aneurysm-Pipeline Insights, 2017

  • January 2017
  • -
  • Delve Insight


DelveInsight’s, “ Aneurysm-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Aneurysm. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Aneurysm. DelveInsight’s Report also assesses the Aneurysm therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope

- The report provides competitivepipeline landscape of Aneurysm
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Aneurysm pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Aneurysm and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Aneurysm-Pipeline Insights, 2017
Illustrative

- Aneurysm Overview
- Aneurysm Pipeline Therapeutics
- Aneurysm Therapeutics under Development by Companies
- Aneurysm Filed and Phase III Products
- Comparative Analysis
- Aneurysm Phase II Products
- Comparative Analysis
- Aneurysm Phase I and IND Filed Products
- Comparative Analysis
- Aneurysm Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Aneurysm - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Aneurysm - Discontinued Products
- Aneurysm - Dormant Products
- Companies Involved in Therapeutics Development for Aneurysm
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Aneurysm, 2017
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2017
- Comparative Analysis Phase II Products, 2017
- Comparative Analysis Phase I and IND Filed Products, 2017
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
- Drug Candidates Profiles
- Aneurysm Assessment by Monotherapy Products
- Aneurysm Assessment by Combination Products
- Aneurysm Assessment by Route of Administration
- Aneurysm Assessment by Stage and Route of Administration
- Aneurysm Assessment by Molecule Type
- Aneurysm Assessment by Stage and Molecule Type
- Aneurysm Therapeutics - Discontinued Products
- Aneurysm Therapeutics - Dormant Products
- Products under Development by Companies, 2017


List of Figures

- Number of Products under Development for Aneurysm, 2017
- Filed and Phase III Products, 2017
- Phase II Products, 2017
- Phase I and IND Filed Products, 2017
- Discovery and Pre-Clinical Stage Products, 2017
- Aneurysm Assessment by Monotherapy Products
- Aneurysm Assessment by Combination Products
- Aneurysm Assessment by Route of Administration
- Aneurysm Assessment by Stage and Route of Administration
- Aneurysm Assessment by Molecule Type
- Aneurysm Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Radiopharmaceutical Market, Nephrology, Neurology, and Immunology - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Radiopharmaceutical Market, Nephrology, Neurology, and Immunology - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5595
  • Industry report
  • October 2016
  • by Transparency Market Research

Radiopharmaceutical Market: Scope and Trends This report on the radiopharmaceutical market analyzes the current and future scenario of the global market. Increase in incidence of various diseases, development ...

Aortic Aneurysm Repair Devices Global Market  – Forecast To 2023

Aortic Aneurysm Repair Devices Global Market – Forecast To 2023

  • $ 4950
  • Industry report
  • January 2017
  • by IQ4I Research & Consultancy Pvt. Ltd

An aneurysm develops due to the weakening of blood vessel which results in a balloon-like dilation. Aneurysms can occur in any artery, it happens most often in the abdominal aorta, an essential blood vessel ...

Global Neurology Devices Market-Growth, Trends, and Forecasts (2016 - 2021)

Global Neurology Devices Market-Growth, Trends, and Forecasts (2016 - 2021)

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global market for neurology devices is expected to reach USD 14.2 billion by the end of 2020, growing at a CAGR of around 13.5% from 2015 to 2020. Electrical stimulation is proving to pacify the symptoms ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.